Newsletter | September 29, 2022

09.29.22 -- EMA Releases Statement Supporting Biosimilar Interchangeability In EU
 
New Podcast Episode
Featured Editorial
Biotech 2016 To 2022 And A Look Ahead
 
By Arda Ural, Ph.D., EY

The last five years have been disruptive regardless of sector, yet biotech managed to weather the storm. This article looks at the past five years in the industry from a macro view and shares what biotech executives should consider in the months ahead.
Attributable Data Integrity In Modern Biopharma Using ALCOA Principles
 
By Kip Wolf, X-Vax Technology, @KipWolf

This article is the first in a five-part series providing contemporary, practical, and useful examples of data integrity within each of the five traditional principles of ALCOA. This article centers on A: Attributable.
Industry Insights
Biotin CAPture Kit Ready-To-Go Interaction Analysis
Infographic | Cytiva

Explore how our single-cycle kinetics (SCK) regularly provides useful results on the first attempt and has a faster result time compared to multicycle kinetics (MCK) experiments.
Developing Biosimilars: Challenges And Solutions
Infographic | Sartorius

Biophysical characterization requires technologies that often need expensive reagents, large quantities of samples, and experimental conditions optimization. Simplified analytical workflows can help.
Wearable Injectors: An Alternative To Traditional Intravenous Administration
Infographic | BD Medical - Pharmaceutical Systems

See a quick visual summary of findings from an early feasibility clinical study featuring a 2-5 mL wearable injector with a viscous placebo.
Sponsor
News Headlines
Solutions
Large Molecule Biologics Made With Intelligent Collaboration
Pfizer CentreOne
Analytical Development And Characterization For AAV
MilliporeSigma (Product Characterization)
Life Science Leader Magazine
 

Have you heard of Life Science Leader?
Check it out today for access to candid interviews with top-tier executives on how they do business.